Rejuvenate Bio
San Diego, California, United States · Biotechnology, Health Care · 15 employees
Rejuvenate Bio is a biotechnology company dedicated to developing novel gene therapies for chronic age-related diseases.
Funding history
- Funding Round — $6.0M — Jun 2026
- Funding Round — $4.0M — Jul 2024
Recent signals
- Jun 09, 2026: Rejuvenate Bio Partners with Merck Animal Health for Strategic R&D Collaboration and $6 Million Financing.
- Jun 08, 2026: Raised $6.0M
- Jul 01, 2024: Raised $4.0M
See plans & pricing → Track Rejuvenate Bio’s funding, hiring, and signals — with verified contacts — on Fundz.